Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Health Stock Jumped 32% Last Month

By Jeremy Bowman - Updated Feb 4, 2021 at 12:41PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Analyst chatter gave the telehealth stock a boost.

What happened

Shares of Teladoc Health (TDOC 6.61%) were moving higher last month as the health tech company benefited from several analyst upgrades in the period. According to data from S&P Global Market Intelligence, the stock finished the month up 31%. 

As you can see from the chart below, the stock gained steadily over the course of the month.

TDOC Chart

TDOC data by YCharts.

So what

Teladoc surged on Jan. 7, climbing 12% after BTIG initiated coverage with a buy rating and a price target of $240, which represented 18% upside from the stock's closing price the day before. Analyst David Larsen noted that healthcare plans are still indicating telehealth is their biggest priority, and that the company is capable of delivering long-term organic growth of 30% to 40% due to the rise of telehealth.

A woman and her child talking to a doctor on a tablet.

Image source: Teladoc.

On Jan. 12, the company received another endorsement, from Piper Sandler, as analyst Sean Wieland gave the stock a price target of $305 and said the company's "fundamentals are attractive, and visibility is improving." The stock gained 4.2% on that news.

The following week, JPMorgan Chase called the stock a top healthcare technology pick, giving it a 3% boost. Shares then jumped on a possible short squeeze, trending with a breakout in WallStreetBets stocks even as there was no news on Teladoc. The elevated trading volume indicated that a squeeze may have pushed the stock higher.

Now what

Teladoc, considered a leader in the fast-growing telehealth field, has been a strong performer over the last year, with shares up 161%. The company has grown through acquisitions (including Livongo Health, which closed on October) and organic growth as it aims to penetrate a high-growth, disruptive field that has been accelerated by the COVID-19 pandemic. 

In its upcoming fourth-quarter earnings report, analysts are expecting a 141% revenue increase, though the company is still expected to lose money for its foreseeable future. With analysts seeming to realize that telehealth is a growth story beyond the pandemic, the healthcare stock could have more upside potential, especially with expectations of triple-digit revenue increases.



Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$32.91 (6.61%) $2.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.